OpenAI Researcher in Talks to Start AI Drug-Discovery Company
Miles Wang, a researcher at OpenAI, is reported to be in funding discussions to launch an AI-driven drug discovery startup valued at about $2 billion. The talks suggest investor interest in using AI to accelerate breakthroughs in life sciences, according to TechCrunch AI.